A Boatload of New Data on Stimulants and Cardiac Events

In 2006, an FDA panel recommended all manufacturers of stimulants to add a “black box” warning about an increased risk of “serious cardiovascular events.”

Current Subscribers

Purchase a subscription

To view the full content, you need to purchase a subscription.